Qu, Y., He, Z., Zhang, X., Yao, X., Xie, Y., Guo, J., Li, J., Hu, B., Bian, J., Liang, C., Xiao, J., Xing, N., Ma, L., Zhang, X., Liu, Z., Chen, H., Zou, Q., Kong, C., Fan, S., Ye, D. (2026). Efficacy with fruquintinib plus sintilimab versus axitinib or everolimus in advanced renal cell carcinoma: A post-hoc analysis from FRUSICA-2 trial by baseline tumor burden.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4533